Extracorporal albumin dialysis (MARS) improves cholestasis and normalizes low apo A-I levels in a patient with benign recurrent intrahepatic cholestasis (BRIC).

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples